British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance

CBA Managment - Blog - British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
  • October 30, 2024
  • by
  • 1 View
  • 0 Comments

[#item_full_content]

Tags :

Leave a Reply

Your email address will not be published. Required fields are marked *

X